Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.64 |
| ▸ | GAA | P10253 | 1/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.58 |
| ▸ | MEN1 | O00255 | 3/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | POLB | P06746 | 2/20 | 0.55 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | GPR174 | Q9BXC1 | 1/20 | 0.54 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL11261484 | 0.98 | KMT2A (0.62) | KMT2AGAAALDH1A1MEN1MAPT | |
| SCHEMBL11752746 | 0.89 | KMT2A (0.56) | KMT2AGAAALDH1A1MEN1MAPT | |
| SCHEMBL18050213 | 0.84 | KMT2A (0.68) | KMT2AGAAALDH1A1MEN1MAPT | |
| SCHEMBL5448009 | 0.84 | KMT2A (0.79) | KMT2AGAAALDH1A1MEN1MAPT | |
| SCHEMBL12735094 | 0.81 | KMT2A (0.64) | KMT2AGAAALDH1A1MEN1MAPT | |
| SCHEMBL525757 | 0.81 | KMT2A (0.69) | KMT2AGAAALDH1A1MEN1MAPT | |
| SCHEMBL25062693 | 0.78 | KMT2A (1.00) | KMT2AGAAALDH1A1MEN1MAPT | |
| SCHEMBL11263094 | 0.78 | KMT2A (0.65) | KMT2AGAAALDH1A1MEN1MAPT | |
| SCHEMBL22365697 | 0.78 | KMT2A (0.60) | KMT2AGAAALDH1A1MEN1MAPT | |
| SCHEMBL11597341 | 0.78 | KMT2A (0.70) | KMT2AGAAALDH1A1MEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2562157-A1 | HETEROARYL (ALKYL) DITHIOCARBAMATE COMPOUNDS, PREPARATION METHODS AND USES THEREOF | Peking University (CN) | 2013-02-27 | — | — | EP | claimed |
| CN-106659765-B | Use of dianhydrogalactitol and analogs or derivatives thereof for treating non-small cell lung cancer and ovarian cancer | 德玛医药 | 2021-08-13 | — | — | CN | disclosed |
| EP-3294284-A1 | COMBINATION OF ANALOGS OR DERIVATIVES OF DIANHYDROGALACTITOL WITH PLATINUM-CONTAINING ANTINEOPLASTIC AGENTS TO TREAT CANCER | Delmar Pharmaceuticals, Inc. (CA) | 2018-03-21 | — | — | EP | disclosed |
| WO-2017075052-A1 | USE OF DIANHYDROGALACTITOL OR DERIVATIVES OR ANALOGS THEREOF FOR TREATMENT OF PEDIATRIC CENTRAL NERVOUS SYSTEM MALIGNANCIES | DELMAR PHARMACEUTICALS, INC. (CA) | 2017-05-04 | — | — | WO | disclosed |
| EP-3125920-A2 | USE OF DIANHYDROGALACTITOL AND ANALOGS OR DERIVATIVES THEREOF TO TREAT NON-SMALL-CELL CARCINOMA OF THE LUNG AND OVARIAN CANCER | Del Mar Pharmaceuticals (CA) | 2017-02-08 | — | — | EP | disclosed |
| WO-2016183331-A1 | COMBINATION OF ANALOGS OR DERIVATIVES OF DIANHYDROGALACTITOL WITH PLATINUM-CONTAINING ANTINEOPLASTIC AGENTS TO TREAT CANCER | DELMAR PHARMACEUTICALS, INC. (CA) | 2016-11-17 | — | — | WO | disclosed |
| EP-3003321-A2 | USE OF DIANHYDROGALACTITOL AND ANALOGS AND DERIVATIVES THEREOF TO TREAT RECURRENT MALIGNANT GLIOMA OR PROGRESSIVE SECONDARY BRIAN TUMOR | Del Mar Pharmaceuticals (CA) | 2016-04-13 | — | — | EP | disclosed |
| EP-2983674-A1 | THERAPEUTIC BENEFIT OF SUBOPTIMALLY ADMINISTERED CHEMICAL COMPOUNDS | Brown, Dennis M. (US) | 2016-02-17 | — | — | EP | disclosed |
| WO-2015154064-A2 | USE OF DIANHYDROGALACTITOL AND ANALOGS OR DERIVATIVES THEREOF TO TREAT NON-SMALL-CELL CARCINOMA OF THE LUNG AND OVARIAN CANCER | DEL MAR PHARMACEUTICALS (CA) | 2015-10-08 | — | — | WO | disclosed |
| WO-2014194312-A2 | USE OF DIANHYDROGALACTITOL AND ANALOGS AND DERIVATIVES THEREOF TO TREAT RECURRENT MALIGNANT GLIOMA OR PROGRESSIVE SECONDARY BRIAN TUMOR | DEL MAR PHARMACEUTICALS (CA) | 2014-12-04 | — | — | WO | disclosed |
| EP-0433393-A1 | TREATMENT OF DAMAGED BONE MARROW AND DOSAGE UNITS THEREFOR. | UNIV ROCHESTER (US) | 1991-06-26 | — | — | EP | disclosed |
| WO-1991005571-A1 | METHOD FOR PRODUCING BONE MARROW GROWTH CELL FACTORS | UNIVERSITY OF ROCHESTER (US) | 1991-05-02 | — | — | WO | disclosed |
| US-4938949-A | Combatting side effects of anticancer drugs with dithiocarbamates | UNIVERSITY OF NEW YORK (US) | 1990-07-03 | — | — | US | disclosed |
| WO-1990002550-A1 | TREATMENT OF DAMAGED BONE MARROW AND DOSAGE UNITS THEREFOR | UNIVERSITY OF ROCHESTER (US) | 1990-03-22 | — | — | WO | disclosed |
| US-4594238-A | Administering platinum compound; then platimun binding compound | REGENTS OF UNIVERSITY OF MINNESOTA (US) | 1986-06-10 | — | — | US | disclosed |
| US-4581224-A | ANTITUMOR, ANTRICARCINOGENIC AGENTS | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1986-04-08 | — | — | US | disclosed |
| US-4313885-A | Furfuryl thiourea compounds | AMERICAN CYANAMID COMPANY (US) | 1982-02-02 | — | — | US | disclosed |
| US-4267191-A | BY ADMINISTERING FURFURYL THIOUREA COMPOUNDS | AMERICAN CYANAMID COMPANY (US) | 1981-05-12 | — | — | US | disclosed |
| US-4152155-A | DRY PROCESSING, HIGH SPEED, NONSILVER PHOTOGRAPHY | EASTMAN KODAK COMPANY (US) | 1979-05-01 | — | — | US | disclosed |
| US-4144062-A | Organotellurium (II) and (IV) compounds in heat-developable photographic materials and process | EASTMAN KODAK COMPANY (US) | 1979-03-13 | — | — | US | disclosed |